Yamamoto Kuniko, Kogiso Tomomi, Taniai Makiko, Hashimoto Etsuko, Tokushige Katsutoshi
Institute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.
JGH Open. 2018 Oct 17;3(1):17-24. doi: 10.1002/jgh3.12097. eCollection 2019 Feb.
Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) have common hepatic histological features, but few studies have compared the genomic backgrounds of these two diseases. Here, we compared the genetic differences between ALD and NAFLD.
This study enrolled 318 Japanese patients with ALD ( = 118; male, 86%; median age, 62 years; liver cirrhosis, 58%; hepatocellular carcinoma [HCC], 31%) and NAFLD ( = 200; male, 55%; age, 61 years; cirrhosis, 19%; HCC, 12%). The genotype frequencies of 10 single nucleotide polymorphisms (SNPs) were analyzed.
The genotype GG and genotype GG were observed more frequently, and the percentage of patients with the genotype GG was lower in ALD compared with NAFLD patients (, 16 4%; 84 44%; 62 72%, respectively; all < 0.01). Comparing noncirrhosis to cirrhosis, the frequency of the potassium voltage-gated channel subfamily Q member 1 () genotype TT and adrenoceptor beta 3 () genotype TT was increased significantly in ALD-related cirrhosis. In contrast, the patatin-like phospholipase 3 () genotype CC was decreased significantly in NAFLD-related cirrhosis. A comparison of patients with and without HCC demonstrated that the genotype TT was increased significantly in both HCC groups. In addition, associations between the genotype GG and ALD-HCC and the G allele of and NAFLD-HCC were identified.
SNPs in genes related to ethanol and lipid metabolism clearly differed between patients with ALD and NAFLD. KCNQ1 might affect the progression and hepatocarcinogenesis in both ALD and NAFLD.
酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)具有共同的肝脏组织学特征,但很少有研究比较这两种疾病的基因组背景。在此,我们比较了ALD和NAFLD之间的遗传差异。
本研究纳入了318例日本ALD患者(n = 118;男性,86%;中位年龄,62岁;肝硬化,58%;肝细胞癌[HCC],31%)和NAFLD患者(n = 200;男性,55%;年龄,61岁;肝硬化,19%;HCC,12%)。分析了10个单核苷酸多态性(SNP)的基因型频率。
GG基因型和 基因型GG观察到的频率更高,与NAFLD患者相比,ALD患者中 基因型GG的患者百分比更低(分别为16±4%、84±44%、62±72%;均P<0.01)。将非肝硬化与肝硬化进行比较,在ALD相关肝硬化中,钾电压门控通道亚家族Q成员1(KCNQ1)基因型TT和肾上腺素能受体β3(ADRB3)基因型TT的频率显著增加。相反,在NAFLD相关肝硬化中,帕他汀样磷脂酶3(PNPLA3)基因型CC显著降低。对有和无HCC的患者进行比较表明,在两个HCC组中 基因型TT均显著增加。此外,还确定了 基因型GG与ALD-HCC以及 的G等位基因与NAFLD-HCC之间的关联。
ALD和NAFLD患者中与乙醇和脂质代谢相关基因的SNP明显不同。KCNQ1可能影响ALD和NAFLD的进展及肝癌发生。